469 (Desvenlafaxine Succinate Extended-Release 50 mg)
Pill with imprint 469 is White, Four-sided and has been identified as Desvenlafaxine Succinate Extended-Release 50 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Desvenlafaxine is used in the treatment of major depressive disorder; depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 469
Desvenlafaxine Succinate Extended-Release
- Imprint
- 469
- Strength
- 50 mg
- Color
- White
- Size
- 9.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Serotonin-norepinephrine reuptake inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 70771-1311
- Inactive Ingredients
-
microcrystalline cellulose,
hypromelloses,
magnesium stearate,
polyethylene glycol,
silicon dioxide,
stearic acid,
magnesium silicate,
titanium dioxide,
xanthan gum
Note: Inactive ingredients may vary.
Related images for "469"
More about desvenlafaxine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,264)
- Drug images
- Pricing & coupons
- En español
- Drug class: serotonin-norepinephrine reuptake inhibitors
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.